Cargando…

Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation

Genetic testing allows for the identification of germline DNA variations, which are associated with a significant increase in the risk of developing breast cancer (BC) and ovarian cancer (OC). Detection of a BRCA1 or BRCA2 pathogenic variant triggers several clinical management actions, which may in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golubeva, Volha A., Nepomuceno, Thales C., Monteiro, Alvaro N. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520942/ https://www.ncbi.nlm.nih.gov/pubmed/31013702 http://dx.doi.org/10.3390/cancers11040522

Ejemplares similares

Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico
por: Dutil, Julie, et al.
Publicado: (2019)

Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
por: Hart, Steven N., et al.
Publicado: (2018)

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective
por: Dutil, Julie, et al.
Publicado: (2015)

Functional Impact of Missense Variants in BRCA1 Predicted by Supervised Learning
por: Karchin, Rachel, et al.
Publicado: (2007)

Functional and Structural Analysis of C-Terminal BRCA1 Missense Variants
por: Quiles, Francisco, et al.
Publicado: (2013)

Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance
por: Woods, Nicholas T, et al.
Publicado: (2016)

Probing Structure-Function Relationships in Missense Variants in the Carboxy-Terminal Region of BRCA1
por: Carvalho, Renato S., et al.
Publicado: (2014)

Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots”
por: Dines, Jennifer N., et al.
Publicado: (2020)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions
por: Hovland, Henrikke Nilsen, et al.
Publicado: (2023)

BRCA1 Circos: a visualisation resource for functional analysis of missense variants
por: Jhuraney, Ankita, et al.
Publicado: (2015)

NECTAR: a database of codon-centric missense variant annotations
por: Gong, Sungsam, et al.
Publicado: (2014)

Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2
por: Tram, Eric, et al.
Publicado: (2013)

In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing
por: Poon, Kok-Siong
Publicado: (2021)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
por: Ferreyra, Yomali, et al.
Publicado: (2023)

Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants
por: Bellè, Francesca, et al.
Publicado: (2022)

Melanoma predisposition—A limited role for germline BRCA1 and BRCA2 variants
por: Adams, David J., et al.
Publicado: (2019)

BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2012)

Gene-specific machine learning for pathogenicity prediction of rare BRCA1 and BRCA2 missense variants
por: Kang, Moonjong, et al.
Publicado: (2023)

Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic
por: Ahlborn, Lise B., et al.
Publicado: (2015)

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants
por: Inagaki-Kawata, Yukiko, et al.
Publicado: (2020)

Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay
por: Nepomuceno, Thales C., et al.
Publicado: (2022)

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants
por: Lambertini, Matteo, et al.
Publicado: (2021)

A common missense variant in BRCA2 predisposes to early onset breast cancer
por: Górski, Bohdan, et al.
Publicado: (2005)

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
por: Edaily, Sarah, et al.
Publicado: (2022)

Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach
por: Rowling, Pamela J. E., et al.
Publicado: (2010)

BRCA1 frameshift variants leading to extended incorrect protein C termini
por: Nepomuceno, Thales C., et al.
Publicado: (2023)

Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics
por: Ernst, Corinna, et al.
Publicado: (2018)

Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
por: Abreu, Renata B. V., et al.
Publicado: (2022)

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
por: Zhang, Yunuo, et al.
Publicado: (2022)

Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
por: Muhammad, Noor, et al.
Publicado: (2023)

BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression
por: Waddell, Nic, et al.
Publicado: (2008)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

BRCA2 BRC missense variants disrupt RAD51-dependent DNA repair
por: Jimenez-Sainz, Judit, et al.
Publicado: (2022)

Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Development of functional assays for BRCA1 missense mutations
por: Sturdy, A, et al.
Publicado: (2008)

Determining the pathogenicity of CFTR missense variants: Multiple comparisons of in silico predictors and variant annotation databases
por: Michels, Marcus, et al.
Publicado: (2019)

Network of Interactions between ZIKA Virus Non-Structural Proteins and Human Host Proteins
por: Golubeva, Volha A., et al.
Publicado: (2020)

A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
por: Kitahara, Miyuki, et al.
Publicado: (2021)

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2
por: Bernstein-Molho, Rinat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pipclq7afi9rm83a29vv4qccer